Document is current
Any future updates will be listed below
-
Authors
Clark, Joseph I. https://orcid.org/0000-0002-0455-2625
Singh, Jatinder
Ernstoff, Marc S.
Lao, Christopher D.
Flaherty, Lawrence E.
Logan, Theodore F.
Curti, Brendan
Agarwala, Sanjiv S.
Taback, Bret
Cranmer, Lee
Lutzky, Jose
Luna, Theresa L.
Aung, Sandra
Lawson, David H.
-
Funding
Funding for this research was provided by:
Prometheus
- License Information
-
More Information
Article History
Received: 25 January 2018
Accepted: 6 July 2018
First Online: 27 July 2018
Ethics approval and consent to participate
: Human investigations were performed after approval by an institutional review board or ethics committee at each participating institution and in accordance with an assurance filed with and approved by the U.S. Department of Health and Human Services. Written informed consent was obtained on all patients.
: Not applicable.
: J.I. Clark: non-paid advisory role – PROCLIVITY registry, Prometheus; advisory board – Exelixis; speakers’ bureau – Bristol-Myers Squibb, Merck; research funding to institution – Acceleron Pharma, Argos Therapeutics, AVEO, Bristol-Myers Squibb, Prometheus, Roche.J. Singh: no competing interests reported.M.S. Ernstoff: no competing interests reported.C.D. Lao: research funding to institution: Bristol-Myers Squibb, Merck, GlaxoSmithKline, Norvatis; travel reimbursement: Bristol-Myers Squibb.L.E. Flaherty: non-paid DSMB role – Merck.T.F. Logan: consulting/advisory role – Prometheus; research funding to institution – Abbott Laboratories, Abraxis BioScience, Acceleron Pharma, AMGEN, Argos Therapeutics, AstraZeneca, AVEO, BioVex, Bristol-Myers Squibb, Eisai, Lilly, GlaxoSmithKline, Roche, immatics, Merck, Novartis, Pfizer, Prometheus, Synta, Thrshold Pharmaceuticals, Millennium, TRACON Pharma, Cerulean, EMD Serono.B. Curti: consulting/advisory role – Prometheus; research support – Prometheus, Galectin Therapeutics, Viralytics; research funding to institution – Bristol-Myers Squibb, MedImmune; speakers’ bureau – Prometheus, Bristol-Myers Squibb.S.S. Agarwala: no competing interests reported.B. Taback: no competing interests reported.L. Cranmer: no competing interests reported.J. Lutzky: no competing interests reported.T.L. Luna: no competing interests reported.S. Aung: no competing interests reported.D.H. Lawson: no competing interests reported.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
